Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06977438 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

GLP-1 Plus Lifestyle for Overall Wellness: Find Your Way Forward

Study acronym: GLOW
StatusNot Yet Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date: Oct 1, 2026 to Oct 15, 2026
    • Eligibility criteria shortened, about 8 words
    • Collaborators: details revised at 1 of 2 entries
  2. Start date: Jan 1, 2027 to Oct 1, 2026
    • Eligibility criteria expanded, about 119 words
    • Study title expanded, about 5 words
    v4
  3. Collaborators expanded, about 7 wordsv3
  4. Primary completion date: Jan 31, 2030 to Jan 31, 2031
    • Start date: Jan 1, 2026 to Jan 1, 2027
    • Study completion date: Jan 31, 2031 to Jan 31, 2032
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
University of Minnesota
328 trials monitored
See 31 trials at risk
Obesity
3,874 trials monitored
See 152 trials at risk
The rapid emergence of new and highly effective obesity medications has turned the field of pediatric weight management on its head. Adolescents living with obesity, their caregivers, healthcare providers, healthcare systems, policymakers, and payors are now wondering what role health behavior and lifestyle treatment (HBLT) has in terms of body mass index (BMI) reduction, improvements in quality of life and cardiometabolic health, and mitigating nutritional concerns when medications are used. Is intensive HBLT needed or could low intensity HBLT be an equally effective alternative; and if so, for whom? Our proposed project will answer these important questions that arise daily in the clinical setting and will generate critical new insights to guide decision-making for teens with obesity and the stakeholders who care deeply about them.
Trial Details
NCT Number NCT06977438
Lead Sponsor University of Minnesota
Collaborators: Patient-Centered Outcomes Research Institute, Novo Nordisk A/S
Conditions
(from sponsor)		 Obesity, Childhood
Related terms Pediatric Obesity
Enrollment 1,020 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov